Target intelligence / Profile preview

Ferriprotoporphyrin IX (Hematin) (FP-IX)

Target
FP-IX
Molecular classification
Metalloporphyrin, Porphyrin derivative, Other
01

Overview

Ferriprotoporphyrin IX (FP-IX), or hematin, is a toxic byproduct produced during the digestion of host hemoglobin by the malaria parasite Plasmodium falciparum (Sullivan, 2002). This process occurs within the parasite's acidic food vacuole, where hemoglobin is broken down to provide amino acids for growth. Because free hematin can generate reactive oxygen species and damage parasite membranes, the parasite detoxifies it by sequestering it into an insoluble crystalline form known as hemozoin or malaria pigment (Hempelmann, 2007). This detoxification pathway is a critical therapeutic target; quinoline-based antimalarials like chloroquine and quinine work by binding to hematin and preventing its crystallization (Egan, 2008). The resulting accumulation of free, toxic hematin leads to the lysis of the parasite's digestive vacuole and subsequent cell death. Despite its historical success as a target, mutations in parasite transporters such as PfCRT have led to widespread resistance by reducing drug concentration at the site of hematin interaction.

Other names
HematinHemeFerrihemeProtoporphyrin IX iron(III) complexMalaria pigment precursor
02

Mechanism of action

Inhibition of hemozoin formation (biocrystallization) by binding to ferriprotoporphyrin IX (hematin), which prevents its detoxification and leads to the accumulation of toxic free heme that causes oxidative damage and parasite death (Egan, 2008; Hempelmann, 2007).

03

Biological functions

Hemoglobin digestion byproductDetoxification substrateCell deathOther
04

Disease associations

Infection
05

Safety considerations

Widespread drug resistance (e.g., PfCRT and PfMDR1 mutations)Potential for oxidative stress in host cells if releasedNarrow therapeutic index and cardiotoxicity (QT prolongation) for certain quinolines
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin levelsParasite clearance ratePfCRT mutationsPfMDR1 mutations

Beyond the preview

Go deeper on Ferriprotoporphyrin IX (Hematin) (FP-IX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferriprotoporphyrin IX (Hematin) (FP-IX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call